Even though exercise testing was not mandatory to confirm the absence of symptoms, the cohort’s low median NT-proBNP concentration and lack of diuretic therapy corroborate the exceedingly early disease stage in the context of the cohort’s advanced age and a significant proportion with atrial fibrillation and ischemic heart disease at diagnosis. The gene discussed is NPPB; the disease is atrial fibrillation.